Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FR3EP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,240
Award facts
- Contract value 100% obligated
- $20,239.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a firm fixed price of $20,239.63 and completion date of August 19, 2025. This non-competitive delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Dupixent (dupilumab) is a monoclonal antibody therapeutic used primarily for treating moderate-to-severe eczema, asthma, and other allergic inflammatory conditions, and its procurement through the DLA supply chain supports military healthcare system requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly for military and veteran healthcare programs. The SPE2DX contract vehicle enables flexible procurement of specialized medications and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Quick answers
Who was awarded contract SPE2DB25FR3EP?
SPE2DB25FR3EP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FR3EP worth?
The government has obligated $20,240 on SPE2DB25FR3EP.
Is contract SPE2DB25FR3EP an order under another contract?
Yes. SPE2DB25FR3EP is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR3EP competed?
The extent of competition for SPE2DB25FR3EP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award